Gene expression profiling of macrophages following mice treatment with an immunomodulator medication

Journal of Cellular Biochemistry

Volumn 104, Issue 4, 2008, Pages 1364-1377

  De Oliveira, Carolina Camargo ^a   De Oliveira, Simone Martins ^a   Goes, Viviane M ^b   Probst, Christian M ^b   Krieger, Marco Aurelio ^b   Buchi, Dorly De Freitas ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Instituto de Biologia Molecular do Parana   (Brazil)

Author keywords

Canova; Cytokines; Gene expression; Macrophages

Indexed keywords

CANOVA; HOMEOPATHIC AGENT; IMMUNOMODULATING AGENT; INTERLEUKIN 2; INTERLEUKIN 4;

ADAPTATION; ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL PROTECTION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IMMUNOMODULATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA TRANSLATION;

ANIMALS; CROTALID VENOMS; CYTOKINES; GENE EXPRESSION PROFILING; IMMUNOLOGIC FACTORS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; PLANT EXTRACTS;

MUS;

EID: 46949087996     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21713     Document Type: Article

References (53)

1. Abud APR, Cesar B, Cavazzani LFM, De Oliveira CC, Gabardo J, Buchi DF. 2006. Activation of bone marrow cells treated with Canova in vitro. Cell Biol Int 30(10):808-816.
2. Adler V, Yin Z, Tew KD, Ronai Z. 1999. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18(45):6104-6111.
3. Alessi DR, Smythe C, Keyse SM. 1993. The human CL100 gene encodes a tyr/thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene 8:2015-2020.
4. Ballow M, Nelson R. 1997. Immunopharmacology: Immunomodulation and immunotherapy. JAMA 278(22):2008-2017.
5. Black PN, DiRusso CC. 2003. Transmembrane movement of exogenous long-chain fatty acids: Proteins, enzymes and vectorial esterification. Microbiol Mol Biol Rev 67(3):454-472.
6. Blocker A, Severin FF, Burkhardt JK, Bingham JB, Yu H, Olivo JC, Schroer TA, Hyman AA, Griffiths G. 1997. Molecular requirements for bi-directional movement of phagosomes along microtubules. J Cell Biol 137(1):113-129.
7. Bradbury A, Belt KT, Neri TM, Milstein C, Calabi F. 1988. Mouse CD1 is distinct from and co-exists with TL in the same thymus. EMBO J 7(10):3081-3086.
8. Brakebusch C, Fässler R. 2003. The integrin-actin connection, an eternal love affair. EMBO J 22(10):2324-2333.
9. Cesar B, Abud APR, de Oliveira CC, Cardoso F, Gremski W, Gabardo J, Buchi DF. Activation of mononuclear bone marrow cells treated in vitro with a complex homeopathic medication. Micron DOI:10.1016/j.micron.2007.02.005
10. Château MT, Robert-Hebmann V, Devaux C, Lazaro JB, Canard B, Coux O. 2001. Human monocytes possess a serine protease activity capable of degrading HIV-1 reverse transcriptase in vitro. Biochem Biophys Res Commun 285(4):863-872.
11. Cote-Sierra J, Foucras G, Guo L, Chiodetti L, Young HA, Hu-Li J, Zhu J, Paul WE. 2004. Interleukin 2 plays a central role in TH2 differentiation. Proc Natl Acad Sci 101(11):3880-3885.
12. De Oliveira CC, Oliveira SM, Godoy LMF, Gabardo J, Buchi DF. 2006. Canova, a Brazilian medical formulation, alters oxidative metabolism of mice macrophages. J Infect 52:420-432.
13. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R, Franzoso G. 2001. Induction of gadd45-beta by NF-kappa-B downregulates pro-apoptotic JNK signaling. Nature 414(6861):308-313.
14. DeRisi JL, Iyerm VR, Brown PO. 1997. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278:680-686.
15. Epstein CB, Butow RA. 2000. Microarray technology - Enhanced versatility, persistent challenge. Curr Opin Biotechnol 11:36-41.
16. Fan X, Krahling S, Smith D, Williamson P, Schlegel RA. 2004. Macrophage surface expression of annexins I and II in the phagocytosis of apoptotic lymphocytes. Mol Biol Cell 15:2863-2872.
17. Forman HJ, Torres M. 2001. Redox signaling in macrophages. Mol Aspects Med 22(4-5):189-216.
18. Frade JMR, Liorente M, Mellado M, Alcami J, Ramos-Gutiérrez JC, Zaballos A, Del Real G, Martinez-A C. 1997. The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. J Clin Invest 100(3):497-502.
19. Houten SM, Wanders RJA, Waterham HR. 2000. Biochemical and genetic aspects of mevalonate kinase and its deficiency. Biochim Biophys Acta: Mol Cell Biol Lipids 1529(1-3):19-32.
20. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31(4):e15.
21. Kambach C, Walke S, Nagai K. 1999. Structure and assembly of the spliceossomal small nuclear ribonucleoprotein particles. Curr Opin Struct Biol 9(2):222-230.
22. Klimp AH, de Vries EGE, Scherphof GL, Daemen T. 2002. A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol 44(2):143-161.
23. Kraal G, van der Laan LJW, Elomaa O, Tryggvason K. 2000. The macrophage receptor MARCO. Microbes Infect 2(3):313-316.
24. Kubo M, Hanada T, Yoshimura A. 2003. Suppressors of cytokine signaling and immunity. Nat Immunol 4(12):1169-1176.
25. Lai L, Alaverdi N, Maltais L, Morse HC III. 1998. Mouse cell surface antigens: Nomenclature and immunophenotyping. J Immunol 160(8):3861-3868.
26. Le Y, Oppenheim JJ, Wang JM. 2001. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev 12(1):91-105.
27. Lopes L, Godoy LMF, de Oliveira CC, Gabardo J, Schadeck RJG, Buchi DF. 2006. Phagocytosis, endosomal/lysosomal system and other cellular aspects of macrophage activation by Canova medication. Micron 37(3):277-287.
28. Mellado M, Frade JMR, Vila-Coro AJ, Fernández S, de Ana AM, Jones DR, Torán JL, Martinez-A C. 2001. Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J 20(10):2497-2507.
29. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, Van Kaer L. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6:469-477.
30. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsiallis SA, Kourembanas S. 2001. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci 98(15):8798-8803.
31. M2 ganglioside activator for phospholipase D activation. Proc Natl Acad Sci 95(21):12249-12253.
32. Ohmori Y, Hamilton TA. 1994. Regulation of macrophage gene expression by T-cell-derived lymphokines. Pharmacol Ther 63:235-264.
33. Pereira WKV, Lonardonib MVC, Grespana R, Caparroz-Assefa SM, Cumana RKN, Bersani-Amadoa CAJ. 2005. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection. J Infect 51:157-164.
34. 1 integrins and actin filaments distribution in intraperitoneal mouse macrophages treated with homeopatic medicament. J Submicroscopy Cytol Pathol 3:255-263.
35. Poliakov A, Cotrina Wilkinson D. 2004. Diverse roles of Eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell 7(4):465-480.
36. Poss KD, Tonegawa S. 1997. Reduced stress in heme-oxygenase 1-deficient cells. Proc Natl Acad Sci 94(20):10925-10930.
37. Rabinowitz S, Horstmann H, Gordon S, Griffiths G. 1992. Immunocytochemical characterization of the endocytic and phagolysosomal compartments in peritoneal macrophages. J Cell Biol 116(1):95-112.
38. Rees RC. 1992. Cytokines as biological response modifiers. J Clin Pathol 45(2):93-98.
39. Saccani A, Saccani S, Orlando S, Sironi M, Bernasconi S, Ghezzi P, Mantovani A, Sica A. 2000. Redox regulation of chemokine receptor expression. Proc Natl Acad Sci 97(4):2761-2766.
40. Sakai K, Higuchi H, Matsubara K, Kato K. 2000. Microarray hybridization with fractionated cDNA: Enhanced identification of differentially expressed genes. Anal Biochem 287(1):32-37.
41. Sasaki MGM, Mariano FC, Gurgel L, Probst S. 2001. Estudo clínico randomizado placebo controlado apara avaliar a eficácia e segurança do Método Canova na terapêutica de pacientes portadores de HIV/AIDS em uso de anti-retrovirais. Braz J Infect Dis 5 (Suppl 1):58.
42. Sato DYO, Wal R, de Oliveira CC, Cattaneo RII, Malvezzi M, Gabardo J, Buchi DF. 2005. Histopathological and immunophenotyping studies on normal and sarcoma 180-bearing mice treated with a complex homeopathic medication. Homeopathy 94:26-32.
43. Sbarba PD, Nencioni L, Labardi D, Rovida E, Caciagli B, Cipolleschi MG. 1996. Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. Cytokine 8(6):488-494.
44. Seligmann IC, Lima PDL, Cardoso PCS, Khayat AS, Bahia MO, Buchi DF, Cabral IR, Burbano R. 2003. The anticancer homeopathic composite "Canova Method" is not genotoxic for human lymphocytes in vitro. Genet Mol Res 2(2):223-228.
45. Singer II, Scott S, Kawka DW, Chin J, Daugherty BL, Demartino JA, Disalvo J, Gould SL, Lineberger JE, Malkowitz L, Miller MD, Mitnaul L, Siciliano SJ, Staruch MJ, Williams HR, Zweerink HJ, Springer MS. 2001. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol 75(8):3779-3790.
46. Stadler BM, Weck AL. 1978. Cytofluorometric analysis of macrophages activated in vivo or in vitro. Eur J Immunol 8:243-246.
47. Takahachi G, Maluf MLF, Svidzinski TIE, Dalalio MMO, Bersani-Amado CA, Cuman RKN. 2006. In vivo and in vitro effects of the Canova medicine on experimental infection with Paracoccidioides brasiliensis in mice. Indian J Pharmacol 38(5):350-354.
48. Tanackovic G, Krämer A. 2005. Human splicing factor SF3a, but not SF1, is essential for pre-mRNA splicing in vivo. Mol Biol Cell 16:1366-1377.
49. Trkola A, Gordon C, Matthews J, Maxwell E, Ketas T, Czaplewski L, Proudfoot AEI, Moore J. 1999. The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity. J Virol 73(8):6370-6379.
50. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci 98(9):5116-5121.
51. Woods A, Couchman JR. 2001. Syndecan-4 and focal adhesion function. Curr Opin Cell Biol 13(5):578-583.
52. Yun PLW, DeCarlo AA, Hunter N. 1999. Modulation of major histocompatibility complex protein expression by human gamma interferon mediated by cysteine proteinase-adhesion polyproteins of Porphyromonas gingivalis. Infect Immun 67(6):2986-2995.
53. Zhou Y, Lin G, Murtaugh MP. 1995. Interleukin-4 suppresses the expression of macrophage NADH oxidase heavy chain subunit (gp91-phox). Biochim Biophys Acta: Mol Cell Res 1265(1):40-48.